Company News

Lumenis to Embark On Photorejuvenation Study

Author Image

By: TOM BRANNA

Editor

Lumenis Ltd., with U.S. operations in New York, NY and Santa Clara, CA, as well as global operations, announced that its IPL Quantum SR Intense Pulsed Light system will be used as part of a new multicenter Phase II clinical study. The study will be carried out at four locations in the U.S. by Dusa Pharmaceuticals Inc., with whom Lumenis has signed a development agreement. IPL provides gentle, non-ablative treatments to remove sun-induced freckles, most benign brown pigments and redness caused b...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters